A gender-based score system predicts the clinical outcome of patients with early B-cell chronic lymphocytic leukemia.
2005-01-01 Molica, S; Mauro, Fr; Callea, V; Gentile, M; Giannarelli, D; Lopez, M; Lauria, F; Rotoli, B; Montanaro, M; Cortelezzi, A; Liso, V; Mandelli, F; Foa, R; GIMEMA CLL Study, Group.
Younger patients with Waldenström Macroglobulinemia exhibit low risk profile and excellent outcomes in the era of immunotherapy and targeted therapies
2020-01-01 Varettoni, M; Ferrari, A; Frustaci, Am; Ferretti, Vv; Rizzi, R; Motta, M; Piazza, F; Merli, M; Benevolo, G; Visco, C; Laurenti, L; Ferrero, S; Gentile, M; Del Fabro, V; Abbadessa, A; Klersy, C; Musto, P; Fabbri, N; Deodato, M; Dogliotti, I; Greco, C; Corbingi, A; Luminari, S; Arcaini, L.
An increased number of individuals with clinically recognized monoclonal B-cell lymphocytosis characterizes a recent database of chronic lymphocytic leukemia Rai stage 0.
2012-01-01 Molica, S; Gentile, M; Mauro, Fr; Brugiatelli, M; Federico, M; Sperduti, I; Neri, A; Ferrarini, M; Foà, R; Morabito, F.
The role of high-dose therapy and autologous stem cell transplantation in patients with primary refractory Hodgkin's lymphoma: a report from the Gruppo Italiano per lo Studio dei Linfomi (GISL).
2006-01-01 Morabito, F; Stelitano, C; Luminari, S; Mammi, C; Marcheselli, L; Callea, V; Gentile, M; Polimeno, G; Merli, F; Molica, S; Gobbi, P; Angrilli, F; Brugiatelli, M; Federico, M.
Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study
2020-01-01 Passamonti, F; Cattaneo, C; Arcaini, L; Bruna, R; Cavo, M; Merli, F; Angelucci, E; Krampera, M; Cairoli, R; Della Porta, Mg; Fracchiolla, N; Ladetto, M; Gambacorti Passerini, C; Salvini, M; Marchetti, M; Lemoli, R; Molteni, A; Busca, A; Cuneo, A; Romano, A; Giuliani, N; Galimberti, S; Corso, A; Morotti, A; Falini, B; Billio, A; Gherlinzoni, F; Visani, G; Tisi, Mc; Tafuri, A; Tosi, P; Lanza, F; Massaia, M; Turrini, M; Ferrara, F; Gurrieri, C; Vallisa, D; Martelli, M; Derenzini, E; Guarini, A; Conconi, A; Cuccaro, A; Cudillo, L; Russo, D; Ciambelli, F; Scattolin, Am; Luppi, M; Selleri, C; Ortu La Barbera, E; Ferrandina, C; Di Renzo, N; Olivieri, A; Bocchia, M; Gentile, M; Marchesi, F; Musto, P; Federici, Ab; Candoni, A; Venditti, A; Fava, C; Pinto, A; Galieni, P; Rigacci, L; Armiento, D; Pane, F; Oberti, M; Zappasodi, P; Visco, C; Franchi, M; Grossi, Pa; Bertù, L; Corrao, G; Pagano, L; Corradini, P; ITA-HEMA-COV, Investigators.
Primary refractory multiple myeloma: a real-world experience with 85 cases
2020-01-01 Jurczyszyn, A; Waszczuk-Gajda, A; Castillo, Jj; Krawczyk, K; Stork, M; Pour, L; Usnarska-Zubkiewicz, L; Potoczek, S; Hus, I; Davila Valls, J; Hari, P; Chhabra, S; Gentile, M; Mikala, G; Varga, G; Chim, Cs; Fiala, M; Vij, R; Schutz, N; Rodzaj, M; Porowska, A; Vesole, Dh; Druzd-Sitek, A; Walewski, J; Nooka, Ak.
Time to progression of mantle cell lymphoma after high-dose cytarabine-based regimens defines patients risk for death.
2018-01-01 Visco, C; Tisi, Mc; Evangelista, A; Di Rocco, A; Zoellner, Ak; Zilioli, Vr; Hohaus, S; Sciarra, R; Re, A; Tecchio, C; Chiappella, A; Morello, L; Gini, G; Nassi, L; Perrone, T; Molinari, Al; Fabbri, A; Cox, Mc; Finolezzi, E; Ferrero, S; Puccini, B; Alvarez De Celis, I; Arcari, A; Marino, D; Merli, M; Piazza, F; Gentile, M; Pelosini, M; Loseto, G; Hermine, O; Dreyling, M; Ruggeri, M; Martelli, M; Hoster, E; Vitolo, U; Fondazione Italiana Linfomi and the Mantle Cell Lymphoma, Network.
Lenalidomide-based induction and maintenance in elderly newly diagnosed multiple myeloma patients: updated results of the EMN01 randomized trial
2019-01-01 Bringhen, S; D'Agostino, M; Paris, L; Ballanti, S; Pescosta, N; Spada, S; Pezzatti, S; Grasso, M; Rota-Scalabrini, D; De Rosa, L; Pavone, V; Gazzera, G; Aquino, S; Poggiu, M; Santoro, A; Gentile, M; Baldini, L; Petrucci, Mt; Tosi, P; Marasca, R; Cellini, C; Palumbo, A; Falco, P; Hájek, R; Boccadoro, M; Larocca, A.
Lenalidomide and low-dose dexamethasone (Rd) versus bortezomib, melphalan, prednisone (VMP) in elderly newly diagnosed multiple myeloma patients: A comparison of two prospective trials.
2016-01-01 Gentile, M; Magarotto, V; Offidani, M; Musto, P; Bringhen, S; Teresa Petrucci, M; Gay, F; Larocca, A; Uccello, G; Petrungaro, A; Vigna, E; Greco, R; Grazia Recchia, A; Tripepi, G; Ria, R; Di Raimondo, F; Palumbo, A; Morabito, F.
Clinical characteristics and treatment outcomes in IgE multiple myeloma: A case-control study.
2018-01-01 Jurczyszyn, A; Castillo, Jj; Vesole, Dh; Liu, J; Avivi, I; Waszczuk-Gajda, A; Lech-Maranda, E; Gentile, M; Mikala, G; Guerrero-Garcia, T; Suska, A; Gertz, Ma.
A multicenter retrospective study of 223 patients with t(14;16) in multiple myeloma
2020-01-01 Goldman-Mazur, S; Jurczyszyn, A; Castillo, Jj; Waszczuk-Gajda, A; Grząśko, N; Radocha, J; Bittrich, M; Kortüm, Km; Gozzetti, A; Usnarska-Zubkiewicz, L; Davila Valls, J; Jayabalan, Ds; Niesvizky, R; Kelman, J; Coriu, D; Rosiñol, L; Szukalski, Ł; González-Calle, V; Mateos, Mv; Jamroziak, K; Hus, I; Avivi, I; Cohen, Y; Suska, A; Chappell, A; Madduri, D; Chhabra, S; Kleman, A; Hari, P; Delforge, M; Robak, P; Gentile, M; Kozłowska, I; Goldberg, Sl; Czepiel, J; Silbermann, R; Olszewski, Aj; Barth, P; Mikala, G; Chim, Cs; Długosz-Danecka, M; Grosicki, S; Vesole, Dh.
Prognostic relevance of serum levels and cellular expression of adiponectin in B-cell chronic lymphocytic leukemia.
2008-01-01 Molica, S; Vitelli, G; Cutrona, G; Todoerti, K; Mirabelli, R; Digiesi, G; Giannarelli, D; Sperduti, I; Molica, M; Gentile, M; Morabito, F; Neri, A; Ferrarini, M.
Small nucleolar RNAs as new biomarkers in chronic lymphocytic leukemia.
2014-01-01 Ronchetti, D; Mosca, L; Cutrona, G; Tuana, G; Gentile, M; Fabris, S; Agnelli, L; Ciceri, G; Matis, S; Massucco, C; Colombo, M; Reverberi, D; Recchia, Ag; Bossio, S; Negrini, M; Tassone, P; Morabito, F; Ferrarini, M; Neri, A.
An in-depth evaluation of acalabrutinib for the treatment of mantle-cell lymphoma
2020-01-01 Morabito, F.; Recchia, A. G.; Vigna, E.; Botta, C.; Skafi, M.; Abu-Rayyan, M.; Atrash, M.; Galimberti, S.; Morabito, L.; Al-Janazreh, H.; Martino, M.; Cutrona, G.; Gentile, M.
The incidence of JAK2 V617F mutation in bcr/abl-negative chronic myeloproliferative disorders: assessment by two different detection methods.
2008-01-01 Lucia, E; Martino, B; Mammi, C; Vigna, E; Mazzone, C; Gentile, M; Qualtieri, G; Bisconte, Mg; Naccarato, M; Gentile, C; Laganà, C; Romeo, F; Neri, A; Nobile, F; Morabito, F.
Direct-Acting Antivirals in Hepatitis C Virus-Associated Diffuse Large B-cell Lymphomas.
2018-01-01 Merli, M; Frigeni, M; Alric, L; Visco, C; Besson, C; Mannelli, L; Di Rocco, A; Ferrari, A; Farina, L; Pirisi, M; Piazza, F; Loustaud-Ratti, V; Arcari, A; Marino, D; Sica, A; Goldaniga, M; Rusconi, C; Gentile, M; Cencini, E; Benanti, F; Rumi, Mg; Ferretti, Vv; Grossi, P; Gotti, M; Sciarra, R; Tisi, Mc; Cano, I; Zuccaro, V; Passamonti, F; Arcaini, L.
A prognostic algorithm including a modified version of MD Anderson Cancer Center (MDACC) score predicts time to first treatment of patients with clinical monoclonal lymphocytosis (cMBL)/Rai stage 0 chronic lymphocytic leukemia (CLL)
2014-01-01 Molica, S; Giannarelli, D; Levato, L; Mirabelli, R; Gentile, M; Lentini, M; Morabito, F.
Safety and efficacy of bortezomib-melphalan-prednisone-thalidomide followed by bortezomib-thalidomide maintenance (VMPT-VT) versus bortezomib-melphalan-prednisone (VMP) in untreated multiple myeloma patients with renal impairment.
2011-01-01 Morabito, F; Gentile, M; Mazzone, C; Rossi, D; Di Raimondo, F; Bringhen, S; Ria, R; Offidani, M; Patriarca, F; Nozzoli, C; Petrucci, Mt; Benevolo, G; Vincelli, I; Guglielmelli, T; Grasso, M; Marasca, R; Baldini, L; Montefusco, V; Musto, P; Cascavilla, N; Majolino, I; Musolino, C; Cavo, M; Boccadoro, M; Palumbo, A.
Survival risk score for real-life relapsed/refractory chronic lymphocytic leukemia patients receiving ibrutinib. A campus CLL study
2020-01-01 Gentile, M; Morabito, F; Del Poeta, G; Mauro, Fr; Reda, G; Sportoletti, P; Laurenti, L; Coscia, M; Herishanu, Y; Recchia, Ag; Varettoni, M; Murru, R; Chiarenza, A; Condoluci, A; Moia, R; Pietrasanta, D; Loseto, G; Consoli, U; Scortechini, I; Rossi, Fm; Zucchetto, A; Fraticelli, V; Vigna, E; Botta, C; Tripepi, G; Arrigo, G; Rago, A; Angeletti, I; Biagi, A; Del Giudice, I; Bomben, R; Rigolin, Gm; Rossi, D; Di Raimondo, F; Gaidano, G; Polliack, A; Cuneo, A; Foà, R; Gattei, V.
Fludarabine + prednisone +/- alpha-interferon followed or not by alpha-interferon maintenance therapy for previously untreated patients with chronic lymphocytic leukemia: long term results of a randomized study.
2003-01-01 Mauro, Fr; Zinzani, P; Zaja, F; Gentile, M; Vegna, Ml; Stefoni, V; Marin, L; Fanin, R; Baccarani, M; Tura, S; Mandelli, F.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A gender-based score system predicts the clinical outcome of patients with early B-cell chronic lymphocytic leukemia. | 1-gen-2005 | Molica, S; Mauro, Fr; Callea, V; Gentile, M; Giannarelli, D; Lopez, M; Lauria, F; Rotoli, B; Montanaro, M; Cortelezzi, A; Liso, V; Mandelli, F; Foa, R; GIMEMA CLL Study, Group. | |
| Younger patients with Waldenström Macroglobulinemia exhibit low risk profile and excellent outcomes in the era of immunotherapy and targeted therapies | 1-gen-2020 | Varettoni, M; Ferrari, A; Frustaci, Am; Ferretti, Vv; Rizzi, R; Motta, M; Piazza, F; Merli, M; Benevolo, G; Visco, C; Laurenti, L; Ferrero, S; Gentile, M; Del Fabro, V; Abbadessa, A; Klersy, C; Musto, P; Fabbri, N; Deodato, M; Dogliotti, I; Greco, C; Corbingi, A; Luminari, S; Arcaini, L. | |
| An increased number of individuals with clinically recognized monoclonal B-cell lymphocytosis characterizes a recent database of chronic lymphocytic leukemia Rai stage 0. | 1-gen-2012 | Molica, S; Gentile, M; Mauro, Fr; Brugiatelli, M; Federico, M; Sperduti, I; Neri, A; Ferrarini, M; Foà, R; Morabito, F. | |
| The role of high-dose therapy and autologous stem cell transplantation in patients with primary refractory Hodgkin's lymphoma: a report from the Gruppo Italiano per lo Studio dei Linfomi (GISL). | 1-gen-2006 | Morabito, F; Stelitano, C; Luminari, S; Mammi, C; Marcheselli, L; Callea, V; Gentile, M; Polimeno, G; Merli, F; Molica, S; Gobbi, P; Angrilli, F; Brugiatelli, M; Federico, M. | |
| Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study | 1-gen-2020 | Passamonti, F; Cattaneo, C; Arcaini, L; Bruna, R; Cavo, M; Merli, F; Angelucci, E; Krampera, M; Cairoli, R; Della Porta, Mg; Fracchiolla, N; Ladetto, M; Gambacorti Passerini, C; Salvini, M; Marchetti, M; Lemoli, R; Molteni, A; Busca, A; Cuneo, A; Romano, A; Giuliani, N; Galimberti, S; Corso, A; Morotti, A; Falini, B; Billio, A; Gherlinzoni, F; Visani, G; Tisi, Mc; Tafuri, A; Tosi, P; Lanza, F; Massaia, M; Turrini, M; Ferrara, F; Gurrieri, C; Vallisa, D; Martelli, M; Derenzini, E; Guarini, A; Conconi, A; Cuccaro, A; Cudillo, L; Russo, D; Ciambelli, F; Scattolin, Am; Luppi, M; Selleri, C; Ortu La Barbera, E; Ferrandina, C; Di Renzo, N; Olivieri, A; Bocchia, M; Gentile, M; Marchesi, F; Musto, P; Federici, Ab; Candoni, A; Venditti, A; Fava, C; Pinto, A; Galieni, P; Rigacci, L; Armiento, D; Pane, F; Oberti, M; Zappasodi, P; Visco, C; Franchi, M; Grossi, Pa; Bertù, L; Corrao, G; Pagano, L; Corradini, P; ITA-HEMA-COV, Investigators. | |
| Primary refractory multiple myeloma: a real-world experience with 85 cases | 1-gen-2020 | Jurczyszyn, A; Waszczuk-Gajda, A; Castillo, Jj; Krawczyk, K; Stork, M; Pour, L; Usnarska-Zubkiewicz, L; Potoczek, S; Hus, I; Davila Valls, J; Hari, P; Chhabra, S; Gentile, M; Mikala, G; Varga, G; Chim, Cs; Fiala, M; Vij, R; Schutz, N; Rodzaj, M; Porowska, A; Vesole, Dh; Druzd-Sitek, A; Walewski, J; Nooka, Ak. | |
| Time to progression of mantle cell lymphoma after high-dose cytarabine-based regimens defines patients risk for death. | 1-gen-2018 | Visco, C; Tisi, Mc; Evangelista, A; Di Rocco, A; Zoellner, Ak; Zilioli, Vr; Hohaus, S; Sciarra, R; Re, A; Tecchio, C; Chiappella, A; Morello, L; Gini, G; Nassi, L; Perrone, T; Molinari, Al; Fabbri, A; Cox, Mc; Finolezzi, E; Ferrero, S; Puccini, B; Alvarez De Celis, I; Arcari, A; Marino, D; Merli, M; Piazza, F; Gentile, M; Pelosini, M; Loseto, G; Hermine, O; Dreyling, M; Ruggeri, M; Martelli, M; Hoster, E; Vitolo, U; Fondazione Italiana Linfomi and the Mantle Cell Lymphoma, Network. | |
| Lenalidomide-based induction and maintenance in elderly newly diagnosed multiple myeloma patients: updated results of the EMN01 randomized trial | 1-gen-2019 | Bringhen, S; D'Agostino, M; Paris, L; Ballanti, S; Pescosta, N; Spada, S; Pezzatti, S; Grasso, M; Rota-Scalabrini, D; De Rosa, L; Pavone, V; Gazzera, G; Aquino, S; Poggiu, M; Santoro, A; Gentile, M; Baldini, L; Petrucci, Mt; Tosi, P; Marasca, R; Cellini, C; Palumbo, A; Falco, P; Hájek, R; Boccadoro, M; Larocca, A. | |
| Lenalidomide and low-dose dexamethasone (Rd) versus bortezomib, melphalan, prednisone (VMP) in elderly newly diagnosed multiple myeloma patients: A comparison of two prospective trials. | 1-gen-2016 | Gentile, M; Magarotto, V; Offidani, M; Musto, P; Bringhen, S; Teresa Petrucci, M; Gay, F; Larocca, A; Uccello, G; Petrungaro, A; Vigna, E; Greco, R; Grazia Recchia, A; Tripepi, G; Ria, R; Di Raimondo, F; Palumbo, A; Morabito, F. | |
| Clinical characteristics and treatment outcomes in IgE multiple myeloma: A case-control study. | 1-gen-2018 | Jurczyszyn, A; Castillo, Jj; Vesole, Dh; Liu, J; Avivi, I; Waszczuk-Gajda, A; Lech-Maranda, E; Gentile, M; Mikala, G; Guerrero-Garcia, T; Suska, A; Gertz, Ma. | |
| A multicenter retrospective study of 223 patients with t(14;16) in multiple myeloma | 1-gen-2020 | Goldman-Mazur, S; Jurczyszyn, A; Castillo, Jj; Waszczuk-Gajda, A; Grząśko, N; Radocha, J; Bittrich, M; Kortüm, Km; Gozzetti, A; Usnarska-Zubkiewicz, L; Davila Valls, J; Jayabalan, Ds; Niesvizky, R; Kelman, J; Coriu, D; Rosiñol, L; Szukalski, Ł; González-Calle, V; Mateos, Mv; Jamroziak, K; Hus, I; Avivi, I; Cohen, Y; Suska, A; Chappell, A; Madduri, D; Chhabra, S; Kleman, A; Hari, P; Delforge, M; Robak, P; Gentile, M; Kozłowska, I; Goldberg, Sl; Czepiel, J; Silbermann, R; Olszewski, Aj; Barth, P; Mikala, G; Chim, Cs; Długosz-Danecka, M; Grosicki, S; Vesole, Dh. | |
| Prognostic relevance of serum levels and cellular expression of adiponectin in B-cell chronic lymphocytic leukemia. | 1-gen-2008 | Molica, S; Vitelli, G; Cutrona, G; Todoerti, K; Mirabelli, R; Digiesi, G; Giannarelli, D; Sperduti, I; Molica, M; Gentile, M; Morabito, F; Neri, A; Ferrarini, M. | |
| Small nucleolar RNAs as new biomarkers in chronic lymphocytic leukemia. | 1-gen-2014 | Ronchetti, D; Mosca, L; Cutrona, G; Tuana, G; Gentile, M; Fabris, S; Agnelli, L; Ciceri, G; Matis, S; Massucco, C; Colombo, M; Reverberi, D; Recchia, Ag; Bossio, S; Negrini, M; Tassone, P; Morabito, F; Ferrarini, M; Neri, A. | |
| An in-depth evaluation of acalabrutinib for the treatment of mantle-cell lymphoma | 1-gen-2020 | Morabito, F.; Recchia, A. G.; Vigna, E.; Botta, C.; Skafi, M.; Abu-Rayyan, M.; Atrash, M.; Galimberti, S.; Morabito, L.; Al-Janazreh, H.; Martino, M.; Cutrona, G.; Gentile, M. | |
| The incidence of JAK2 V617F mutation in bcr/abl-negative chronic myeloproliferative disorders: assessment by two different detection methods. | 1-gen-2008 | Lucia, E; Martino, B; Mammi, C; Vigna, E; Mazzone, C; Gentile, M; Qualtieri, G; Bisconte, Mg; Naccarato, M; Gentile, C; Laganà, C; Romeo, F; Neri, A; Nobile, F; Morabito, F. | |
| Direct-Acting Antivirals in Hepatitis C Virus-Associated Diffuse Large B-cell Lymphomas. | 1-gen-2018 | Merli, M; Frigeni, M; Alric, L; Visco, C; Besson, C; Mannelli, L; Di Rocco, A; Ferrari, A; Farina, L; Pirisi, M; Piazza, F; Loustaud-Ratti, V; Arcari, A; Marino, D; Sica, A; Goldaniga, M; Rusconi, C; Gentile, M; Cencini, E; Benanti, F; Rumi, Mg; Ferretti, Vv; Grossi, P; Gotti, M; Sciarra, R; Tisi, Mc; Cano, I; Zuccaro, V; Passamonti, F; Arcaini, L. | |
| A prognostic algorithm including a modified version of MD Anderson Cancer Center (MDACC) score predicts time to first treatment of patients with clinical monoclonal lymphocytosis (cMBL)/Rai stage 0 chronic lymphocytic leukemia (CLL) | 1-gen-2014 | Molica, S; Giannarelli, D; Levato, L; Mirabelli, R; Gentile, M; Lentini, M; Morabito, F. | |
| Safety and efficacy of bortezomib-melphalan-prednisone-thalidomide followed by bortezomib-thalidomide maintenance (VMPT-VT) versus bortezomib-melphalan-prednisone (VMP) in untreated multiple myeloma patients with renal impairment. | 1-gen-2011 | Morabito, F; Gentile, M; Mazzone, C; Rossi, D; Di Raimondo, F; Bringhen, S; Ria, R; Offidani, M; Patriarca, F; Nozzoli, C; Petrucci, Mt; Benevolo, G; Vincelli, I; Guglielmelli, T; Grasso, M; Marasca, R; Baldini, L; Montefusco, V; Musto, P; Cascavilla, N; Majolino, I; Musolino, C; Cavo, M; Boccadoro, M; Palumbo, A. | |
| Survival risk score for real-life relapsed/refractory chronic lymphocytic leukemia patients receiving ibrutinib. A campus CLL study | 1-gen-2020 | Gentile, M; Morabito, F; Del Poeta, G; Mauro, Fr; Reda, G; Sportoletti, P; Laurenti, L; Coscia, M; Herishanu, Y; Recchia, Ag; Varettoni, M; Murru, R; Chiarenza, A; Condoluci, A; Moia, R; Pietrasanta, D; Loseto, G; Consoli, U; Scortechini, I; Rossi, Fm; Zucchetto, A; Fraticelli, V; Vigna, E; Botta, C; Tripepi, G; Arrigo, G; Rago, A; Angeletti, I; Biagi, A; Del Giudice, I; Bomben, R; Rigolin, Gm; Rossi, D; Di Raimondo, F; Gaidano, G; Polliack, A; Cuneo, A; Foà, R; Gattei, V. | |
| Fludarabine + prednisone +/- alpha-interferon followed or not by alpha-interferon maintenance therapy for previously untreated patients with chronic lymphocytic leukemia: long term results of a randomized study. | 1-gen-2003 | Mauro, Fr; Zinzani, P; Zaja, F; Gentile, M; Vegna, Ml; Stefoni, V; Marin, L; Fanin, R; Baccarani, M; Tura, S; Mandelli, F. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista40393
- 2 Contributo in Volume2
Data di pubblicazione
- In corso di stampa37
- 2020 - 202713195
- 2010 - 201915036
- 2000 - 20097892
- 1990 - 19993088
- 1980 - 19891038
- 1971 - 1979109
Editore
- Society for information display2
- TAYLOR & FRANCIS LTD, 4 PARK SQUA...2
- "Il pensiero scientifico" Editore1
- American Physical Society1
- Athens Institute for Education an...1
- Deputazione Storia Patria per la ...1
- Edizioni Scientifiche Calabresi1
- ELSEVIER SCIENCE BV, PO BOX 211, ...1
- ETS1
- Geological Society of America Spe...1
Rivista
- JOURNAL OF HIGH ENERGY PHYSICS498
- PHYSICS LETTERS. SECTION B469
- THE EUROPEAN PHYSICAL JOURNAL. C,...397
- PHYSICAL REVIEW LETTERS272
- MOLECULES176
- PHYSICAL REVIEW D173
- BOLLETTINO FILOSOFICO168
- INTERNATIONAL JOURNAL OF MOLECULA...166
- APPLIED SCIENCES164
- FILOLOGIA ANTICA E MODERNA151
Serie
- ATINER'S CONFERENCE PAPER SERIES1
- INTERNATIONAL REVIEW OF NEUROBIOLOGY1
Keyword
- Humans268
- COVID-19164
- Italy154
- Calabria113
- Hadron-Hadron Scattering111
- Female110
- High Energy Physics - Experiment106
- Palladium105
- Hadron-Hadron scattering (experim...95
- Carbonylation88
Lingua
- eng28604
- ita6840
- fre287
- spa245
- ger96
- grc23
- alb18
- por16
- tur12
- lat10
Accesso al fulltext
- no fulltext39866
- open457
- reserved44
- restricted21
- internalNetwork5
- embargoed1
- partially open1